Navigation Links
National Jewish Health receives patent for diagnostic method of autoimmune chronic urticaria
Date:11/1/2010

National Jewish Health has received a US patent for a method of detecting autoimmune chronic urticaria, which will help assure many patients that dramatic changes in lifestyle are not needed to treat the condition. Ronald Harbeck, PhD, Medical Director of the Advanced Diagnostic Laboratories at National Jewish Health, and colleagues Drs. Karen Andrews and Donald MacGlashan, Jr. developed the diagnostic assay, which makes use of the protein CD203c as a marker for the condition. The test, offered by the diagnostic laboratories at National Jewish Health, has been highly successful, with 250 to 300 tests run every week for patients around the nation.

Chronic urticaria is recurrent hives that last for six weeks or longer. They can be caused by allergic and non-allergic reactions. It is often difficult to pin down a specific cause. Without a known cause, many patients will try various adjustments to their lifestyles in an often unsuccessful attempt to cure the hives.

"Patients will often try eliminating foods from their diet or pets from their homes and alter their medications, believing they are suffering from allergic reactions," said Dr. Harbeck.

Approximately 40 percent of chronic urticaria patients have an autoimmune form of the disease, which is essentially a malfunction of the immune system and has no external cause. Doctors can prescribe a variety of treatments for chronic urticaria, based on symptoms, but rarely prescribe a significant change in lifestyle. The recently granted patent describes a method for detecting this autoimmune form of chronic urticaria.

"This diagnostic method will allow some patients to continue their normal, daily lives knowing that they are not suffering from an allergic condition," said Dr. Harbeck.

The invented method includes detecting the expression of the protein CD203c on cells in the presence of the antibody present in chronic urticaria patients.

"The creation of this diagnostic test is a reflection of the quality of research performed by our scientists and the commitment from National Jewish Health to support the advancement of research discoveries towards clinical applications in the spirit of our brand promise, Science Transforming Life," said Emmanuel Hilaire, PhD, Manager of the Technology Transfer Office at National Jewish Health.


'/>"/>

Contact: William Allstetter
allstetterw@njhealth.org
303-398-1002
National Jewish Health
Source:Eurekalert

Related medicine news :

1. NationalCreditReport.com Reminds Consumers of Ways to Improve Credit Report and Score in 2010
2. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
3. National Wildlife Federation Says Outdoor Time for Kids Can Help First Lady Achieve Her “Let's Move” Goal
4. Howard Dean to Speak at the 2010 DTC National Conference
5. International Diabetes Federation awards $2 million to 9 global diabetes research projects
6. Jion Beijing Great Wall International Travel Agency Immediate Exposure to China Expo 2010
7. U.S. National Guard Connects Nationwide with Desktop Alert's Command and Control Mass Notification Systems and Common Alerting Protocol (CAP)
8. H1N1 international symposium to be hosted by Emory-UGA Influenza Center
9. The Alliance for a Healthier Generation Names Celtics Captain Paul Pierce National Athlete Spokesperson in the Fight Against Childhood Obesity
10. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
11. Protecting patients: Study shows that Johns Hopkins flu vaccination rates twice national average
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... , ... Providing broad access to life-saving drugs and rewarding the innovators who ... to address this problem. , That was the message from Dana Goldman, PhD, Leonard ... University of Southern California, who served as the keynote speaker for Western University of ...
(Date:4/21/2017)... ... April 21, 2017 , ... Evoke ... young adults, has kicked off its 4th annual Forum for Innovative Treatment Solutions ... is “Attachment Informed Therapy for Mental Health and Addiction.” , FITS’ 2017 ...
(Date:4/21/2017)... ... April 21, 2017 , ... The adage “Show, don’t ... the next project in the company’s esteemed VISION House demonstration project series. Manifesting the ... the amount of resources they need to live affordably and abundantly without unduly taxing ...
(Date:4/21/2017)... ... April 21, 2017 , ... Crossover Symmetry , ... , an active lifestyle company that provides Human Performance Training and education to ... offers, first responders, military officers and others in service through the development and ...
(Date:4/21/2017)... ... April 21, 2017 , ... Northern California Medical ... Care Spring Symposium on April 1, 2017 in Santa Rosa. This well-attended annual ... healthcare providers an opportunity to learn about cutting edge treatments, to collaborate, share ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), ... Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Executive Officer of the Company is scheduled to present on Tuesday, ... and the Chairman of the Board, Tony Holler ... ...
(Date:4/19/2017)... 2017 Global Surgical Drainage Device Market: Overview ... to remove excess liquid and air. The fluid to ... or lymph. Surgical drains are used in a wide ... surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. Common use ... accumulation of fluid e.g. blood or pus. Surgical drains ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
Breaking Medicine Technology: